Skip to main content
. Author manuscript; available in PMC: 2024 Apr 20.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005618. doi: 10.1161/CIRCOUTCOMES.119.005618

Table 1.

Baseline Characteristics of Patients With AMICS, CS Without AMI, and Mixed Shock

AMICS, % (n) CS Without
AMI, % (n)
Mixed, % (n) P Value
N=136 N=314 N=132
Demographics
 Age, median (IQR), y 68 (59–76) 63 (53–73) 65 (54–75) 0.008
 Female sex 33.1 (45) 37.6 (118) 37.1 (49) 0.65
 White race 76.5 (91) 65.6 (181) 66.7 (74) 0.093
 Weight, median (IQR), kg 83 (70–95) 82 (69–97) 82 (68–98) 0.96
 BMI, median (IQR), kg/m2 28 (25–32) 28 (24–32) 28 (24–34) 0.64
Cardiovascular comorbidities
 Current smoker 23.7 (32) 13.8 (43) 11.5 (15) 0.002
 Diabetes mellitus 50.0 (68) 35.7 (112) 44.7 (59) 0.011
 Hypertension 72.1 (98) 53.5 (168) 60.6 (80) 0.001
 Coronary artery disease 48.5 (66) 40.1 (126) 47.0 (62) 0.18
 Cerebrovascular disease 10.3 (14) 8.3 (26) 7.6 (10) 0.70
 Peripheral artery disease 13.2 (18) 8.9 (28) 11.4 (15) 0.36
 Prior heart failure 26.5 (36) 62.1 (195) 54.5 (72) <0.001
 Historical LVEF*
  ≥50% 8.3 (3) 11.6 (22) 19.7 (13) 0.044
  40–<50% 13.9 (5) 5.8 (11) 4.5 (3)
  30–<40% 16.7 (6) 10.0 (19) 15.2 (10)
  20–<30% 38.9 (14) 27.9 (53) 31.8 (21)
  <20% 22.2 (8) 44.7 (85) 28.8 (19)
 Prior heart transplant 0.0 (0) 1.3 (4) 3.8 (5) 0.036
 Atrial fibrillation 10.3 (14) 29.0 (91) 27.3 (36) <0.001
 Ventricular arrhythmia 3.7 (5) 12.1 (38) 8.3 (11) 0.017
 Severe valvular disease 2.2 (3) 15.6 (49) 26.5 (35) <0.001
 Pulmonary hypertension 0.7 (1) 9.9 (31) 3.8 (5) <0.001
 Congenital heart disease 0.7 (1) 1.6 (5) 3.0 (4) 0.34
Noncardiovascular comorbidities
 Chronic kidney disease 24.3 (33) 35.4 (111) 35.6 (47) 0.053
 On dialysis 12.1 (4) 15.3 (17) 42.6 (20) <0.001
 Significant pulmonary disease 11.0 (15) 18.8 (59) 13.6 (18) 0.086
 Significant liver disease 2.9 (4) 4.8 (15) 6.8 (9) 0.33

Categorical variables are shown as percentages with counts in parentheses. Continuous variables are shown as medians with interquartile ranges (IQRs). Differences between patients in each group were evaluated using Pearson χ2 test for categorical variables and Kruskal-Wallis test for continuous variables. *Among patients with prior heart failure. †Among patients with chronic kidney disease. AMI indicates acute myocardial infarction; AMICS, acute myocardial infarction with cardiogenic shock; BMI, body mass index; CS, cardiogenic shock; and LVEF, left ventricular ejection fraction.